{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:09:03Z","timestamp":1789088943842,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Projects of Chongqing Natural Science Foundation","award":["CSTB2024NSCQ-KJFZZDX0019"],"award-info":[{"award-number":["CSTB2024NSCQ-KJFZZDX0019"]}]},{"name":"New Chongqing Youth Innovation Talent Project","award":["CSTB2024NSCQ-QCXMX0031"],"award-info":[{"award-number":["CSTB2024NSCQ-QCXMX0031"]}]},{"name":"Chongqing Science and Health Joint Medical Science and Technology Innovation and Key Project","award":["2025GGXM001"],"award-info":[{"award-number":["2025GGXM001"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0529400 & 2024ZD0529406"],"award-info":[{"award-number":["2024ZD0529400 & 2024ZD0529406"]}]},{"name":"The Key Projects of Talent Incubation Plan of Xinqiao Hospital","award":["2023YQB010&2024YQB078"],"award-info":[{"award-number":["2023YQB010&2024YQB078"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02181-9","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:37:15Z","timestamp":1781512635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PYCR1 promotes glutamine metabolism and the progression of lung adenocarcinoma by regulating the expression of OPLAH"],"prefix":"10.1007","volume":"26","author":[{"given":"Wei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufeng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4223-2750","authenticated-orcid":false,"given":"Peng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6725-385X","authenticated-orcid":false,"given":"Quanxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"3","key":"2181_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2181_CR2","first-page":"87","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"2181_CR3","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.trecan.2024.07.008","volume":"10","author":"E Redin","year":"2024","unstructured":"Redin E, Quintanal-Villalonga \u00c1, Rudin CM. Small cell lung cancer profiling: an updated synthesis of subtypes, vulnerabilities, and plasticity. Trends cancer. 2024;10(10):935\u201346.","journal-title":"Trends cancer"},{"issue":"11","key":"2181_CR4","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1056\/NEJMicm1802514","volume":"379","author":"L Conti","year":"2018","unstructured":"Conti L, Gatt S. Squamous-Cell Carcinoma of the Lung. N Engl J Med. 2018;379(11):e17.","journal-title":"N Engl J Med"},{"issue":"7689","key":"2181_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446\u201354.","journal-title":"Nature"},{"issue":"21","key":"2181_CR6","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/jama.2025.0560","volume":"333","author":"SY Kim","year":"2025","unstructured":"Kim SY, Park HS, Chiang AC. Small Cell Lung Cancer: A Review. JAMA. 2025;333(21):1906\u201317.","journal-title":"JAMA"},{"issue":"1","key":"2181_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12957-025-03701-9","volume":"23","author":"S Xin","year":"2025","unstructured":"Xin S, Wen M, Tian Y, Dong H, Wan Z, Jiang S, Meng F, Xiong Y, Han Y. Impact of histopathological subtypes on invasive lung adenocarcinoma: from epidemiology to tumour microenvironment to therapeutic strategies. World J Surg Oncol. 2025;23(1):66.","journal-title":"World J Surg Oncol"},{"issue":"33","key":"2181_CR8","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1200\/JCO.21.01691","volume":"39","author":"S Devarakonda","year":"2021","unstructured":"Devarakonda S, Li Y, Martins Rodrigues F, Sankararaman S, Kadara H, Goparaju C, Lanc I, Pepin K, Waqar SN, Morgensztern D, et al. Genomic Profiling of Lung Adenocarcinoma in Never-Smokers. J Clin oncology: official J Am Soc Clin Oncol. 2021;39(33):3747\u201358.","journal-title":"J Clin oncology: official J Am Soc Clin Oncol"},{"issue":"2","key":"2181_CR9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jtcvs.2024.05.009","volume":"169","author":"CN Fick","year":"2025","unstructured":"Fick CN, Dunne EG, Vanstraelen S, Toumbacaris N, Tan KS, Rocco G, Molena D, Huang J, Park BJ, Rekhtman N, et al. High-risk features associated with recurrence in stage I lung adenocarcinoma. J Thorac Cardiovasc Surg. 2025;169(2):436\u2013e444436.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"11","key":"2181_CR10","doi-asserted-by":"publisher","first-page":"e14646","DOI":"10.1111\/ijcp.14646","volume":"75","author":"F Cimen","year":"2021","unstructured":"Cimen F, D\u00fczg\u00fcn S, Aloglu M, Senturk A, Atikcan S. Molecular properties and survival of lung adenocarcinoma in young patients. Int J Clin Pract. 2021;75(11):e14646.","journal-title":"Int J Clin Pract"},{"issue":"1","key":"2181_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The Emerging Hallmarks of Cancer Metabolism. Cell Metabol. 2016;23(1):27\u201347.","journal-title":"Cell Metabol"},{"key":"2181_CR12","doi-asserted-by":"publisher","first-page":"1507845","DOI":"10.3389\/fimmu.2025.1507845","volume":"16","author":"RZ Wu","year":"2025","unstructured":"Wu RZ, Sun QQ, Fu Y, Yu HN, Liu WY, Wu YH, Zhang H, Pan YL, Rui X. Fatty acid metabolism-derived prognostic model for lung adenocarcinoma: unraveling the link to survival and immune response. Front Immunol. 2025;16:1507845.","journal-title":"Front Immunol"},{"key":"2181_CR13","doi-asserted-by":"crossref","unstructured":"Chen Y, Zhou Y, Ren R, Chen Y, Lei J, Li Y. Harnessing lipid metabolism modulation for improved immunotherapy outcomes in lung adenocarcinoma. J Immunother Cancer 2024, 12(7).","DOI":"10.1136\/jitc-2024-008811"},{"issue":"10","key":"2181_CR14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nrc.2016.71","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman BJ, Stine ZE, Dang CV. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat Rev Cancer. 2016;16(10):619\u201334.","journal-title":"Nat Rev Cancer"},{"key":"2181_CR15","doi-asserted-by":"crossref","unstructured":"Katt WP, Lukey MJ, Cerione RA. A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis. Future Med Chem 2017, 9(2):223\u201343.","DOI":"10.4155\/fmc-2016-0190"},{"key":"2181_CR16","doi-asserted-by":"publisher","first-page":"1608407","DOI":"10.3389\/fimmu.2025.1608407","volume":"16","author":"Y Chi","year":"2025","unstructured":"Chi Y, Ma G, Liu Q, Xiang Y, Liu D, Du J. Multi-omics analysis reveals glutathione metabolism-related immune suppression and constructs a prognostic model in lung adenocarcinoma. Front Immunol. 2025;16:1608407.","journal-title":"Front Immunol"},{"issue":"12","key":"2181_CR17","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.7150\/thno.55482","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X, Yu K, Ma L, Qian Z, Tian X, Miao Y, Niu Y, Xu X, Guo S, Yang Y, et al. Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma. Theranostics. 2021;11(12):5650\u201374.","journal-title":"Theranostics"},{"issue":"1","key":"2181_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13045-022-01359-4","volume":"15","author":"T Liu","year":"2022","unstructured":"Liu T, Han C, Fang P, Ma Z, Wang X, Chen H, Wang S, Meng F, Wang C, Zhang E, et al. Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma. J Hematol Oncol. 2022;15(1):141.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"2181_CR19","first-page":"3780","volume":"12","author":"X Wei","year":"2022","unstructured":"Wei X, Zhang X, Wang S, Wang Y, Ji C, Yao L, Song N. PYCR1 regulates glutamine metabolism to construct an immunosuppressive microenvironment for the progression of clear cell renal cell carcinoma. Am J Cancer Res. 2022;12(8):3780\u201398.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"2181_CR20","doi-asserted-by":"publisher","first-page":"2545620","DOI":"10.1080\/14756366.2025.2545620","volume":"40","author":"P Guo","year":"2025","unstructured":"Guo P, Wu C, Wang T, Song Y, Liu X, Wang X, Zhu Y, Song B, Zhu Y, Zhang J, et al. The key enzyme PYCR1 in proline metabolism: a dual driver of cancer progression and fibrotic remodeling. J Enzyme Inhib Med Chem. 2025;40(1):2545620.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"2181_CR21","first-page":"131","volume":"4","author":"X Chen","year":"1998","unstructured":"Chen X, Schecter RL, Griffith OW, Hayward MA, Alpert LC, Batist G. Characterization of 5-oxo-L-prolinase in normal and tumor tissues of humans and rats: a potential new target for biochemical modulation of glutathione. Clin Cancer Res. 1998;4(1):131\u20138.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2181_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.21873\/cgp.20386","volume":"20","author":"D Shimizu","year":"2023","unstructured":"Shimizu D, Kanda M, Kishida T, Nakamura S, Sasahara M, Ueda S, Sato Y, Inokawa Y, Hattori N, Hayashi M, et al. OPLAH Protein Expression Stratifies the Prognosis of Patients With Squamous Cell Carcinoma of the Esophagus. Cancer Genomics Proteom. 2023;20(4):343\u201353.","journal-title":"Cancer Genomics Proteom"},{"key":"2181_CR23","doi-asserted-by":"publisher","first-page":"1064127","DOI":"10.3389\/fonc.2022.1064127","volume":"12","author":"S He","year":"2022","unstructured":"He S, Zhang S, Yao Y, Xu B, Niu Z, Liao F, Wu J, Song Q, Li M, Liu Z. Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment. Front Oncol. 2022;12:1064127.","journal-title":"Front Oncol"},{"issue":"4","key":"2181_CR24","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","volume":"55","author":"J Jin","year":"2023","unstructured":"Jin J, Byun JK, Choi YK, Park KG. Targeting glutamine metabolism as a therapeutic strategy for cancer. Exp Mol Med. 2023;55(4):706\u201315.","journal-title":"Exp Mol Med"},{"issue":"3","key":"2181_CR25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2016.01.007","volume":"23","author":"SM Davidson","year":"2016","unstructured":"Davidson SM, Papagiannakopoulos T, Olenchock BA, Heyman JE, Keibler MA, Luengo A, Bauer MR, Jha AK, O\u2019Brien JP, Pierce KA, et al. Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer. Cell Metabol. 2016;23(3):517\u201328.","journal-title":"Cell Metabol"},{"issue":"8","key":"2181_CR26","doi-asserted-by":"publisher","first-page":"111691","DOI":"10.1016\/j.celrep.2022.111691","volume":"41","author":"D Yang","year":"2022","unstructured":"Yang D, Liu H, Cai Y, Lu K, Zhong X, Xing S, Song W, Zhang Y, Ye L, Zhu X, et al. Branched-chain amino acid catabolism breaks glutamine addiction to sustain hepatocellular carcinoma progression. Cell Rep. 2022;41(8):111691.","journal-title":"Cell Rep"},{"issue":"3","key":"2181_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1158\/0008-5472.CAN-23-1443","volume":"84","author":"H Fan","year":"2024","unstructured":"Fan H, Xu Z, Yao K, Zheng B, Zhang Y, Wang X, Zhang T, Li X, Hu H, Yue B, et al. Osteoclast Cancer Cell Metabolic Cross-talk Confers PARP Inhibitor Resistance in Bone Metastatic Breast Cancer. Cancer Res. 2024;84(3):449\u201367.","journal-title":"Cancer Res"},{"issue":"1","key":"2181_CR28","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1038\/s41467-024-48364-4","volume":"15","author":"W Lu","year":"2024","unstructured":"Lu W, Cui J, Wang W, Hu Q, Xue Y, Liu X, Gong T, Lu Y, Ma H, Yang X, et al. PPIA dictates NRF2 stability to promote lung cancer progression. Nat Commun. 2024;15(1):4703.","journal-title":"Nat Commun"},{"issue":"12","key":"2181_CR29","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s00726-021-02999-5","volume":"53","author":"AN Bogner","year":"2021","unstructured":"Bogner AN, Stiers KM, Tanner JJ. Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target. Amino Acids. 2021;53(12):1817\u201334.","journal-title":"Amino Acids"},{"issue":"12","key":"2181_CR30","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1016\/j.celrep.2018.02.084","volume":"22","author":"KER Hollinshead","year":"2018","unstructured":"Hollinshead KER, Munford H, Eales KL, Bardella C, Li C, Escribano-Gonzalez C, Thakker A, Nonnenmacher Y, Kluckova K, Jeeves M, et al. Oncogenic IDH1 Mutations Promote Enhanced Proline Synthesis through PYCR1 to Support the Maintenance of Mitochondrial Redox Homeostasis. Cell Rep. 2018;22(12):3107\u201314.","journal-title":"Cell Rep"},{"issue":"10","key":"2181_CR31","doi-asserted-by":"publisher","first-page":"e70045","DOI":"10.1002\/ctm2.70045","volume":"14","author":"H Wang","year":"2024","unstructured":"Wang H, Xu M, Zhang T, Pan J, Li C, Pan B, Zhou L, Huang Y, Gao C, He M, et al. PYCR1 promotes liver cancer cell growth and metastasis by regulating IRS1 expression through lactylation modification. Clin translational Med. 2024;14(10):e70045.","journal-title":"Clin translational Med"},{"issue":"2","key":"2181_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10863-021-09887-3","volume":"53","author":"S Du","year":"2021","unstructured":"Du S, Sui Y, Ren W, Zhou J, Du C. PYCR1 promotes bladder cancer by affecting the Akt\/Wnt\/\u03b2-catenin signaling. J Bioenerg Biomembr. 2021;53(2):247\u201358.","journal-title":"J Bioenerg Biomembr"},{"issue":"1","key":"2181_CR33","doi-asserted-by":"publisher","first-page":"6117","DOI":"10.1038\/s41467-023-41658-z","volume":"14","author":"K Zheng","year":"2023","unstructured":"Zheng K, Sha N, Hou G, Leng Z, Zhao Q, Zhang L, He L, Xu M, Jiang Y, Chen T. IGF1R-phosphorylated PYCR1 facilitates ELK4 transcriptional activity and sustains tumor growth under hypoxia. Nat Commun. 2023;14(1):6117.","journal-title":"Nat Commun"},{"key":"2181_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbrc.2021.02.029","volume":"550","author":"J Lu","year":"2021","unstructured":"Lu J, Lin J, Zhou Y, Ye K, Fang C. MiR-328-3p inhibits lung adenocarcinoma-genesis by downregulation PYCR1. Biochem Biophys Res Commun. 2021;550:99\u2013106.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"2181_CR35","first-page":"1475","volume":"38","author":"H Wang","year":"2023","unstructured":"Wang H, He D. LINC01123 acts as an oncogenic driver in lung adenocarcinoma by regulating the miR-4766-5p\/PYCR1 axis. Histol Histopathol. 2023;38(12):1475\u201386.","journal-title":"Histol Histopathol"},{"key":"2181_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.canlet.2020.01.019","volume":"474","author":"CL Kuo","year":"2020","unstructured":"Kuo CL, Chou HY, Chiu YC, Cheng AN, Fan CC, Chang YN, Chen CH, Jiang SS, Chen NJ, Lee AY. Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis. Cancer Lett. 2020;474:138\u201350.","journal-title":"Cancer Lett"},{"issue":"6","key":"2181_CR37","doi-asserted-by":"publisher","first-page":"e27628","DOI":"10.1016\/j.heliyon.2024.e27628","volume":"10","author":"L Sun","year":"2024","unstructured":"Sun L, Tuo Z, Chen X, Wang H, Lyu Z, Li G. Identification of cell differentiation trajectory-related gene signature to reveal the prognostic significance and immune landscape in prostate cancer based on multiomics analysis. Heliyon. 2024;10(6):e27628.","journal-title":"Heliyon"},{"issue":"1","key":"2181_CR38","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s13018-025-05716-0","volume":"20","author":"S Qiu","year":"2025","unstructured":"Qiu S, Tan C, Cheng D, Yang Q. Identification and verification of a polyamine metabolism-related gene signature for predicting prognosis and immune infiltration in osteosarcoma. J Orthop Surg Res. 2025;20(1):482.","journal-title":"J Orthop Surg Res"},{"issue":"14","key":"2181_CR39","doi-asserted-by":"publisher","first-page":"6495","DOI":"10.1016\/S0021-9258(18)68670-3","volume":"263","author":"LY Li","year":"1988","unstructured":"Li LY, Seddon AP, Meister A. Interaction of the protein components of 5-oxoprolinase. Substrate-dependent enzyme complex formation. J Biol Chem. 1988;263(14):6495\u2013501.","journal-title":"J Biol Chem"},{"issue":"13","key":"2181_CR40","doi-asserted-by":"publisher","first-page":"e2306814121","DOI":"10.1073\/pnas.2306814121","volume":"121","author":"D Wang","year":"2024","unstructured":"Wang D, Tang M, Zhang P, Yang K, Huang L, Wu M, Shen Q, Yue J, Wang W, Gong Y, et al. Activation of ER\u03b2 hijacks the splicing machinery to trigger R-loop formation in triple-negative breast cancer. Proc Natl Acad Sci USA. 2024;121(13):e2306814121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2181_CR41","doi-asserted-by":"crossref","unstructured":"Ishak M, Baharudin R, Rose IM, Sagap I, Mazlan L, Azman ZAM, Abu N, Jamal R, Lee LH, Mutalib NSA. Genome-Wide Open Chromatin Methylome Profiles in Colorectal Cancer. Biomolecules 2020, 10(5).","DOI":"10.3390\/biom10050719"},{"key":"2181_CR42","doi-asserted-by":"publisher","first-page":"103753","DOI":"10.1016\/j.redox.2025.103753","volume":"85","author":"X Guo","year":"2025","unstructured":"Guo X, Jiang M, Tao Z, Dai H, Wu C, Wang Y, Wang Z, Wang X, Zhang Z, Qian K, et al. 5-Oxoproline prevents doxorubicin-induced cardiotoxicity and tumor growth. Redox Biol. 2025;85:103753.","journal-title":"Redox Biol"},{"issue":"16","key":"2181_CR43","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1073\/pnas.1002459107","volume":"107","author":"S Suzuki","year":"2010","unstructured":"Suzuki S, Tanaka T, Poyurovsky MV, Nagano H, Mayama T, Ohkubo S, Lokshin M, Hosokawa H, Nakayama T, Suzuki Y, et al. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci U S A. 2010;107(16):7461\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2181_CR44","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1038\/s12276-025-01577-z","volume":"57","author":"JH Shin","year":"2025","unstructured":"Shin JH, Kim JY, Kim MJ, Kang Y, Lee HJ, Choi B, Lee JS, Kwon D, Kim SH, Sung Y, et al. PYCR1 drives lung cancer progression through functional interactions with EGFR and TLR signaling pathways. Exp Mol Med. 2025;57(11):2559\u201373.","journal-title":"Exp Mol Med"},{"issue":"10","key":"2181_CR45","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11538-024-01346-5","volume":"86","author":"R Abukwaik","year":"2024","unstructured":"Abukwaik R, Vera-Siguenza E, Tennant D, Spill F. p53 Orchestrates Cancer Metabolism: Unveiling Strategies to Reverse the Warburg Effect. Bull Math Biol. 2024;86(10):124.","journal-title":"Bull Math Biol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02181-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02181-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02181-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:27:30Z","timestamp":1789086450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02181-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2181"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02181-9","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All of the authors declare that there is no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors agree to the publication of this article.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been reviewed by the Laboratory Animal Welfare and Ethics Committee of the Third Military Medical University and meets animal ethics and animal welfare requirements. Ethics number: AMUWEC20255470)","order":3,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"328"}}